Metrikler
Yayın
9
Açık Erişim
1
BM Sürdürülebilir Kalkınma Amaçları
Araştırma Alanları
Tıp
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Makaleler
Tümü (8)
SCI-E, SSCI, AHCI (7)
SCI-E, SSCI, AHCI, ESCI (8)
Scopus (6)
2025
20251. Interplay of gut microbiome and metabolome in various blood pressure phenotypes based on ambulatory BP monitoring reveal new insights in nondipper patients
Ozbek D. A., Koc N. S., Inal N., ERDOĞAN KABLAN S., KAYGUSUZ Y., KARAHAN S., et al.
JOURNAL OF HYPERTENSION
, cilt.43, sa.9, ss.1539-1553, 2025 (SCI-Expanded, Scopus)
2025
20252. The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors
ŞAHİN T. K., GÜVEN D. C., Durukan M., KAVGACI G., KAYGUSUZ Y., ARIK Z., et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
, sa.4, ss.129-137, 2025 (SCI-Expanded)
2025
20253. The association between HALP score and survival in patients treated with immune checkpoint inhibitors
ŞAHİN T. K., GÜVEN D. C., Durukan M., BAŞ O., KAYGUSUZ Y., ARIK Z., et al.
EXPERT REVIEW OF ANTICANCER THERAPY
, sa.1, ss.81-89, 2025 (SCI-Expanded)
2025
20254. The perspectives and knowledge of patients with cancer on mpox and mpox vaccination: a cross-sectional study
ŞAHİN T. K., KAYGUSUZ Y., Icli M. C., AKSOY S., GÜVEN D. C.
CURRENT MEDICAL RESEARCH AND OPINION
, sa.1, ss.83-91, 2025 (SCI-Expanded, Scopus)
2024
20245. Impact of opioid analgesics on survival in cancer patients receiving immune checkpoint inhibitors
KAVGACI G., GÜVEN D. C., KAYGUSUZ Y., KARACA E., DİZDAR Ö., Kilickap S., et al.
SUPPORTIVE CARE IN CANCER
, cilt.32, sa.7, 2024 (SCI-Expanded, Scopus)
2023
20236. Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data
Guven D. C., ERUL E., KAYGUSUZ Y., Akagunduz B., Kilickap S., De Luca R., et al.
Supportive Care in Cancer
, cilt.31, sa.12, 2023 (SCI-Expanded, Scopus)
2023
20237. Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab
YILDIRIM H. Ç., KUŞ F., GÜVEN D. C., Karaca E., KAYGUSUZ Y., DİZDAR Ö., et al.
Journal of Immunotherapy and Precision Oncology
, cilt.6, sa.4, ss.170-176, 2023 (Scopus)
2023
20238. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma
GÜVEN D. C., ERUL E., YILMAZ F., YAŞAR S., YILDIRIM H. Ç., ERCAN F., et al.
European Archives of Oto-Rhino-Laryngology
, cilt.280, sa.5, ss.2471-2478, 2023 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2024
20241. Exploring the interplay between gut microbiome, fecal metabolomics and ambulatory blood pressure in white-coat hypertensive patients
ÖZBEK D. A., KOÇ N. S., nal N. e., ERDOĞAN KABLAN S., KAYGUSUZ Y., KARAHAN S., et al.
61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)